Value-Based Care

A Tulsa jury found a doctor negligent, awarding $15M to a girl left with severe brain damage after a missed diagnosis of bacterial meningitis as an infant.

With backing from GV and Dexcom, Signos is using AI and OTC glucose monitors to offer a new path for sustainable weight management beyond GLP-1 drugs.

With a new COO, CPO, and CTO, the health-tech firm is poised to expand its AI platform that automates crucial care tasks between hospital visits.

New preclinical data shows RTY-406 could be a first-in-class therapy for PSC, a progressive liver disease with no effective treatments.

Free skin cancer screenings in Ottawa highlight a national health crisis as wait times soar and experts demand urgent government action on specialist care.

Wellness brand Le-Vel is launching a telehealth service for prescription peptides, blurring the lines between direct sales and mainstream medicine.

Vanda Pharmaceuticals' rare disease drug gets a key designation in Japan, unlocking major incentives and promising a new treatment for a severe skin disease.

With CHF 105 million in new funding, NUCLIDIUM is advancing its novel copper-based radiotheranostics for metastatic prostate and breast cancer.

A Canadian pilot's daring evacuation in the DRC highlights a new Ebola crisis, as a rare, untreatable strain spreads through the conflict-ridden region.

John Theurer Cancer Center presents breakthroughs in CAR-T, ADCs, and health equity at ASCO, offering new hope for patients worldwide.

As fatal opioid overdoses triple, a new mobile treatment clinic arrives in Ellensburg, offering a crucial lifeline and eliminating a major barrier to care.

Village Medical Arizona and others are now Bookmark Medical. Discover the strategy behind this national rebranding and its impact on patient care.

Ionetix wins FDA approval for its generic prostate cancer imaging agent, a move set to boost access and shake up the competitive radiopharmaceutical market.

Triage Cancer and Bright Spot Network launch a free national program offering legal, financial, and emotional support to families facing a parent's illness.

ValGenesis's upcoming event explores AI's pivotal role in pharma validation, charting a course from digital systems to intelligent, compliant operations.

A new analysis reveals most insured Americans can't access obesity drugs, even with coverage, due to restrictive insurance hurdles.

A new industry of expert guides is emerging to help patients navigate a broken healthcare system. Here’s how it works and why it’s growing so fast.

With the hire of Loïc Juillard, TailorCare signals a major push to scale its AI-driven platform in the competitive musculoskeletal care market.

A new report reveals Europe's medically-focused cannabis market is finally waking, creating a new global blueprint but also intense competition and price wars.

MBX Biosciences prepares for the Jefferies conference, with investors eyeing updates on its late-stage hypoparathyroidism drug and promising obesity portfolio.